Capricor Therapeutics Inc... (CAPR)
NASDAQ: CAPR
· Real-Time Price · USD
6.16
-0.53 (-7.92%)
At close: Oct 16, 2025, 3:59 PM
6.29
2.11%
After-hours: Oct 16, 2025, 07:59 PM EDT
-7.92% (1D)
| Bid | 4.61 |
| Market Cap | 281.62M |
| Revenue (ttm) | 13.39M |
| Net Income (ttm) | -69.98M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -3.87 |
| Forward PE | -7.7 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.8 |
| Volume | 1,300,275 |
| Avg. Volume (20D) | 1,511,365 |
| Open | 6.75 |
| Previous Close | 6.69 |
| Day's Range | 6.13 - 6.82 |
| 52-Week Range | 5.68 - 22.90 |
| Beta | 0.69 |
| Ex-Dividend Date | n/a |
About CAPR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CAPR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CAPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCapricor Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+12.39%
Capricor Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
+21.36%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
